Skip to content

Clinical trials

Phase 1 Pancreatic Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 1 Country / region: United Kingdom Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20072
20081
20101
20111
20121
20153
20174
20182
20191
20201
20212
20222
20232
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated6
Recruiting4
Active, not recruiting3
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cancer Research UK3
ADC Therapeutics S.A.2
Eli Lilly and Company2
Pfizer2
University of Oxford2
Active Biotech AB1
Amgen1
Astellas Pharma Global Development, Inc.1
Astellas Pharma Inc1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms30
Carcinoma, Non-Small-Cell Lung14
Colorectal Neoplasms7
Ovarian Neoplasms7
Breast Neoplasms6
Melanoma6
Carcinoma, Ovarian Epithelial5
Triple Negative Breast Neoplasms5
Carcinoma, Renal Cell4
Neoplasm Metastasis4

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.